Literature DB >> 889730

Beta-human chorionic gonadotrophin and carcino-embryonic antigen in the management of ovarian carcinoma.

M Stone, K D Bagshawe, A Kardana, F Searle, J Dent.   

Abstract

Measurements of HCG and carcino-embryonic antigen (CEA) were made in 26 patients with ovarian cancer to evaluate these substances as tumour markers; 13-4 per cent of 194 CEA estimations and 14-6 per cent of 144 HCG estimations were abnormal. CEA values were abnormal in 9 out of 26 patients and HCG values in 13 out of 26 patients. The implications of these findings particularly the presence of HCG are discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 889730     DOI: 10.1111/j.1471-0528.1977.tb12602.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  5 in total

1.  Markers in gynaecological cancer.

Authors:  K D Bagshawe; M Wass; F Searle
Journal:  Arch Gynecol       Date:  1980

2.  The detection and measurement of oncodevelopmental proteins in gynecological malignant disease.

Authors:  C Cerni; G Tatra
Journal:  Arch Gynecol       Date:  1982

3.  A case of mucinous cystadenocarcinoma of the ovary associated with virilization: pre and post-operative steroid plasma levels.

Authors:  D Mango; P Scirpa; F Battaglia; S Sentinelli; E Menini
Journal:  J Endocrinol Invest       Date:  1985-08       Impact factor: 4.256

4.  Products of gynaecological neoplasms: clinical and pathological applications.

Authors:  A M Neville
Journal:  Arch Gynecol       Date:  1980

5.  Oncofoetal antigens in cancer of the cervix and ovary.

Authors:  M N Cauchi; S H Koh; D Lim; D L Hay
Journal:  Br J Cancer       Date:  1981-09       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.